Friday, September 10th

Kimpton Hotel Eventi
Ventana Ballroom
New York City, NY

7:15-8:00 a.m. Breakfast

8:00-8:15 a.m. Welcome and Introduction: Improving Health Outcomes (Stacie J. Bell, PhD, Chief Scientific and Medical Officer, Randy Beranek, President and CEO, Iannis Adamopoulos, PhD and Joseph Merola, M.D., MMSc, Symposium Co-Chairs)

8:15-8:25 a.m. Opening Address: Improving Health Outcomes Through Education, Collaboration and Advocacy (Michelle McMurry-Heath, M.D., PhD)

8:25-8:35 a.m. Welcome and Perspectives from NIAMS (Lindsey Criswell, M.D., MPH, Director of NIAMS)

8:35-10:30 a.m. Clinical Research (Moderator: Joseph Merola, M.D., MMSc and April Armstrong, M.D., MPH)

• Addressing Racial/Ethnic Health Disparities in Psoriasis (Junko Takeshita, MD, PhD, MSCE)
• Psoriasis and Skin of Color (Seemal Desai, M.D.)
• The Impact of Obesity in Psoriatic Disease (Alexis Ogdie, M.D., MSCE)
• Getting to the Heart of the Matter: Psoriasis, Inflammation, and Cardiovascular Risk (Michael Garshick, M.D.)
• Emulating Trials with Real-World Data Studies (Seoyoung Kim, M.D., ScD)

10:30-10:50 a.m. Coffee Break

10:50-12:00 p.m. Translational Research (Moderators: John Throup, PhD and Steve Fakharzadeh, MD, PhD)

• Single Cell-omics of Psoriatic Disease (Wilson Liao, M.D.)
• Psoriatic Disease and the Microbiome (Jose Scher, M.D.)

12:00-1:00 p.m. Lunch

1:00-1:45 p.m. NPF Beverly Foster Lectureship: Neutrophil subsets and NETs in the pathogenesis of systemic autoimmune diseases (Marianna Kaplan M.D., Chief of the Systemic Autoimmunity Branch and Deputy Scientific Director at NIAMS)

1:45-3:40 p.m. Basic Science (Moderator: Iannis Adamopoulos, DPhil and Christopher Ritchlin M.D.)

• Ace2: From discovery to a possible universal COVID Therapy (Josef Penninger MD, PhD)
• Insights Into Autoimmune Cellular Cascades: PsA and RA v. Immune Checkpoint Inhibitor-Induced Arthritis (Laura Donlin, PhD)
• Improving Health Outcomes: How Basic Science can Help Identify, Treat, and Prevent Psoriatic Comorbidities (Nicole Ward, PhD)
• Psoriatic Arthritis: Historical Perspectives and Future Directions (Christopher Ritchlin, M.D.)

 3:40-4:15 p.m. Oral Presentations from Selected Abstracts (Moderator: Nicole Ward PhD)

• “IL-23 maintains tissue resident memory Th17 cells in murine and psoriatic skin” (Sarah Whitley, M.D., PhD)
• “MHC haplotype controls the development IL-23 minicircle-induced murine spondyloarthritis” (Emma Haley)
• “Metabolic changes during the transition from psoriasis to psoriatic arthritis: a longitudinal analysis” (Ananta Paine, PhD)
• Awards Presentation (Presenters Joe Merola and Iannis Adamopoulos)

4:15-4:45pm Mental Health Disease Burden of Psoriatic Disease (George Gondo, MA)

• SPECIAL INCLUSION: A Patient’s Perspective (Ayesha Patrick)

4:45-5:00 p.m. Leading Collaborative, Transformational Research – PPI Competitive Renewal Award (Stacie J. Bell, PhD, Chief Scientific and Medical Officer)

5-6:30 p.m. Poster Session/Networking Reception (Beer, wine and light fare provided)